Back to rankings
Quinz

Quinz

More information

Belgium

3

Private equity

Quinz is particularly active within the life sciences, technology and industrial sectors. The practice is well-equipped to advise buy-side PE and VC funds on a range of transactional, regulatory and contentious matters. Bart Lintermans demonstrates notable expertise in real estate transactions, while Klaas Thibaut focuses on the sports and life sciences sectors. The team has been further bolstered by the arrival of Willem Witters from Stibbe in September 2024, bringing expertise in public M&A and equity capital markets. The three co-lead the team.
Legal 500 Editorial commentary

Accolades

Client satisfaction: Billing & efficiency

Testimonials

Collated independently by Legal 500 research team.

  • ‘Efficient, to-the-point, quick response.’
  • ‘Pragmatic and useful advice that brings solutions.’
  • ‘Very hands on, knows our firm's practice after one transaction and very responsive.’

Key clients

  • BNP Paribas Fortis Private Equity Belgium
  • Only Creative Entrepreneurs
  • Ackermans & van Haaren
  • Gimv
  • Cim Capital
  • Driehaus Capital Management
  • Worxinvest
  • EyeCare Group
  • Normec
  • Ampersand Capital Partners

Work highlights

Advised BNP Paribas Fortis Private Equity Belgium on its exit from Gouden Carolus brewery (Het Anker) and on a strategic investment in Anima Research.
Advised Ackermans & van Haaren and Driehaus Capital Management on their €60m Series B investment in Confo Therapeutics.
Advised EyeCare Group, backed by EMK Capital, on the acquisition of Vision Over Sight.
Practice head

Bart Lintermans; Klaas Thibaut; Willem Witters

Comparative Guides